COMMUNIQUÉS West-GlobeNewswire

Ikerian Announces Series B Funding First close of USD 8M (CHF 6.73M) Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

16/10/2024 - 09:00

First close Series B funding round raises USD 8M (CHF 6.73M) led by new investor, Sanoptis, with participation from existing investors the THINC Ventures arm of Topcon Healthcare, Inc, Zürcher Kantonalbank and Verve [...]

Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer

16/10/2024 - 08:00

Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer Newly established role at Essential Pharma further strengthens leadership team and supports global growth Dr Liz Holmes’ rare disease [...]

Tecan provides update on current trading and revised outlook for full year 2024

16/10/2024 - 07:15

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan provides update on current trading and revised outlook for full year 2024 Substantial reductions in OEM customer forecasts as [...]

Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update

16/10/2024 - 07:00

BV100 Phase 2 preliminary results suggest BV100 is generally safe and well tolerated and showed strong initial signs of efficacy in VABP patients Strategic investment from GIBF and launch of BV100 clinical program in [...]

New data on aprocitentan to be presented at the ASN Kidney Week 2024

16/10/2024 - 07:00

Allschwil, Switzerland – October 16, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, Idorsia’s endothelin receptor antagonist, will be presented at the American Society of Nephrology (ASN) [...]

Olivier Falut appointed EUROAPI’s Chief Financial Officer

16/10/2024 - 07:00

Press Release Paris – October 16, 2024 – Olivier Falut has been appointed EUROAPI’s Chief Financial Officer, effective October 17, 2024, and will be a member of the Executive Committee. He is taking over from Evelyne [...]

Olivier Falut est nommé Directeur financier d’EUROAPI

16/10/2024 - 07:00

Communiqué de presse Paris – Le 16 octobre 2024 – Olivier Falut a été nommé Directeur financier d’EUROAPI, à compter du 17 octobre 2024, et sera membre du Comité Exécutif. Il succède à Evelyne Nguyen, qui restera au [...]

HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial

16/10/2024 - 06:30

— New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer — — MET is a common biomarker in this setting for patients who develop resistance to EGFR [...]

Arch Biopartners Arranges Non-Brokered Private Placement

16/10/2024 - 00:23

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering of 290,323 common [...]

Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System

15/10/2024 - 23:21

CARLSBAD, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal [...]

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024

15/10/2024 - 22:34

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market [...]

Publication relating to transparency notifications

15/10/2024 - 22:30

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]

Publication relative à des notifications de transparence

15/10/2024 - 22:30

INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 15 octobre 2024 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

15/10/2024 - 22:30

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]

Amwell announces new chief financial officer

15/10/2024 - 22:30

Industry veteran Mark Hirschhorn joins Amwell leadership team BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial [...]

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

15/10/2024 - 22:30

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after [...]

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15/10/2024 - 22:15

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory [...]

Biodexa Announces Successful Appeal of Nasdaq Delisting

15/10/2024 - 22:15

Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company [...]

Sanofi: Information concerning the total number of voting rights and shares - September 2024

15/10/2024 - 22:05

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]